Stockscreener 앱 받기
2.77
0.00%
0.00
시간 외 거래:
2.77
전일 마감가:
$2.77
열려 있는:
$2.75
하루 거래량:
82,202
Relative Volume:
0.36
시가총액:
$92.46M
수익:
$210.00K
순이익/손실:
$-10.40M
주가수익비율:
-8.7964
EPS:
-0.3149
순현금흐름:
$-6.88M
1주 성능:
-3.15%
1개월 성능:
-5.14%
6개월 성능:
-16.06%
1년 성능:
-11.78%
1일 변동 폭
$2.68
$2.7882
1주일 범위
$2.68
$2.94
52주 변동 폭
$2.331
$5.4566
Anixa Biosciences Inc Stock (ANIX) Company Profile
명칭
Anixa Biosciences Inc
전화
408-708-9808
주소
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE
Compare ANIX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANIX
Anixa Biosciences Inc
|
2.77 | 92.46M | 210.00K | -10.40M | -6.88M | -0.3149 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Anixa Biosciences Inc Stock (ANIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 개시 | Maxim Group | Buy |
| 2022-12-23 | 개시 | Chardan Capital Markets | Buy |
| 2021-04-12 | 개시 | H.C. Wainwright | Buy |
Anixa Biosciences Inc 주식(ANIX)의 최신 뉴스
Exclusive: Anixa Biosciences' ovarian cancer drug candidate shows longer survival with no major safety issues - MSN
Anixa Biosciences (NASDAQ:ANIX) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Anixa Biosciences AGM: Shareholders Back Directors as CEO Highlights CAR-T, Vaccine Progress - MarketBeat
Can Anixa Biosciences Inc keep up with sector leadersTrade Risk Assessment & Verified Stock Trade Ideas - baoquankhu1.vn
Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast - Barchart
Anixa Biosciences Shareholders Back Board and Compensation - TipRanks
Anixa Biosciences (NASDAQ: ANIX) investors approve directors, pay and auditor - Stock Titan
Anixa Biosciences, Inc. (ANIX) Shareholder/Analyst CallSlideshow (NASDAQ:ANIX) 2026-03-11 - Seeking Alpha
Anixa Biosciences : 2026 Annual Meeting of Shareholders Presentation - marketscreener.com
Anixa Biosciences Inc. Q1 2026 Financial Report: Earnings, Balance Sheet, and Key Disclosures - Minichart
Anixa receives Korean patent allowance for breast cancer vaccine By Investing.com - Investing.com Canada
Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology - irw-press.com
Anixa Biosciences Inc reports results for the quarter ended January 31Earnings Summary - TradingView
ANIXA BIOSCIENCES ($ANIX) Releases Q1 2026 Earnings - Quiver Quantitative
Anixa Biosciences (NASDAQ:ANIX) Posts Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Anixa 10-Q: $0 Revenue, $(0.08) EPS for Q3 (Jan 31, 2026) - TradingView
Anixa Biosciences (NASDAQ: ANIX) narrows loss and advances cancer vaccine and CAR-T programs - Stock Titan
Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2026 - marketscreener.com
Anixa Biosciences Receives Notice of Allowance from Korean Minis - GuruFocus
Anixa Biosciences (ANIX) Secures Patent in South Korea for Breas - GuruFocus
Anixa receives Korean patent allowance for breast cancer vaccine - Investing.com India
Anixa Biosciences (NASDAQ:ANIX) Upgraded to Hold at Wall Street Zen - MarketBeat
Anixa Biosciences Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
ANIX SEC FilingsAnixa Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ANIX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Anixa Biosciences (ANIX) to Release Earnings on Tuesday - MarketBeat
Anixa Biosciences to host 2026 annual meeting of stockholders and provide corporate update highlighting recent clinical and regulatory progress - marketscreener.com
Anixa Biosciences To Host 2026 Annual Meeting Of Stockholders And Provide Corporate Update Highlighting Recent Clinical And Regulatory Progress - TradingView
Anixa to outline ovarian CAR-T survival, breast cancer vaccine data - Stock Titan
Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat - Investing News Network
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote - GuruFocus
Co-inventor of Anixa cancer CAR-T to headline 2026 cell therapy retreat - Stock Titan
Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic - Intellectia AI
Can Anixa Biosciences Inc. stock double in the next yearJuly 2025 Weekly Recap & Long Hold Capital Preservation Plans - mfd.ru
ANIX: Robust 2025 Milestones Set the Stage for a Pivotal 2026 - Smartkarma
Anixa Biosciences to Present at the iAccess Alpha Virtual Best I - GuruFocus
Whale Trades: Will Anixa Biosciences Inc. stock reach all time highs in 2025 - mfd.ru
Breast cancer vaccine now in early clinical trials: What to know - abcnews.com
Will Anixa Biosciences Inc. stock reach all time highs in 20252025 Price Targets & Community Consensus Trade Alerts - mfd.ru
Why Anixa Biosciences Inc. stock is seen as undervalued2025 Fundamental Recap & Reliable Breakout Forecasts - mfd.ru
Anixa Biosciences Updates Ovarian Cancer CAR-T Trial Outcomes - Intellectia AI
Aug Momentum: Can Anixa Biosciences Inc maintain its current growth rate2025 Valuation Update & Weekly High Return Stock Forecasts - baoquankhu1.vn
Can Anixa Biosciences Inc. keep up with sector leadersJuly 2025 Sentiment & Risk Managed Investment Entry Signals - mfd.ru
Anixa Biosciences CEO Calls 2026 “Pivotal” as Breast Cancer Vaccine, Ovarian CAR-T Advance - MarketBeat
ANIX: Pivotal data from advanced cancer trials and fiscal discipline set the stage for a transformative 2026 - TradingView
Anixa reports promising survival data in ovarian cancer CAR-T trial - Investing.com Australia
Anixa Biosciences Reports Encouraging Patient Survival Observati - GuruFocus
Why Anixa Biosciences Inc. stock is trending among retail tradersWeekly Trend Recap & Daily Profit Focused Screening - mfd.ru
Anixa Biosciences (ANIX) Reports Positive Data in Ovarian Cancer CAR-T Trial - GuruFocus
Anixa Advances Ovarian Cancer CAR-T With Higher Dosing - TipRanks
Anixa Biosciences Inc (ANIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):